These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35726548)

  • 1. Ferric sulfate pulpotomy in primary teeth with different base materials: a 2-year randomized controlled trial.
    Aksoy B; Güngör HC; Uysal S; Gonzales CD; Ölmez S
    Quintessence Int; 2022 Sep; 53(9):782-789. PubMed ID: 35726548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiographic success rates of mineral trioxide aggregate and ferric sulphate pulpotomies performed by dental students.
    Odabaş ME; Alaçam A; Sillelioğlu H; Deveci C
    Eur J Paediatr Dent; 2012 Jun; 13(2):118-22. PubMed ID: 22762173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary molar pulpotomies with different hemorrhage control agents and base materials: A randomized clinical trial.
    Atasever G; Keceli TI; Uysal S; Gungor HC; Olmez S
    Niger J Clin Pract; 2019 Mar; 22(3):305-312. PubMed ID: 30837416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
    Erdem AP; Guven Y; Balli B; Ilhan B; Sepet E; Ulukapi I; Aktoren O
    Pediatr Dent; 2011; 33(2):165-70. PubMed ID: 21703067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up.
    Yildirim C; Basak F; Akgun OM; Polat GG; Altun C
    J Clin Pediatr Dent; 2016; 40(1):14-20. PubMed ID: 26696101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiographic success of (partial) pulpotomy and pulpectomy in primary teeth: A systematic review.
    Boutsiouki C; Frankenberger R; Krämer N
    Eur J Paediatr Dent; 2021 Dec; 22(4):273-285. PubMed ID: 35034465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
    Airen P; Shigli A; Airen B
    J Clin Pediatr Dent; 2012; 37(2):143-7. PubMed ID: 23534319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary molar pulpotomy: a systematic review and network meta-analysis.
    Lin PY; Chen HS; Wang YH; Tu YK
    J Dent; 2014 Sep; 42(9):1060-77. PubMed ID: 24513112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
    Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Ferric Sulfate Combined Mineral Trioxide Aggregate Pulpotomy and Zinc Oxide Eugenol Pulpectomy of Primary Maxillary Incisors: An 18-month Randomized, Controlled Trial.
    Nguyen TD; Judd PL; Barrett EJ; Sidhu N; Casas MJ
    Pediatr Dent; 2017 Jan; 39(1):34-38. PubMed ID: 28292339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth.
    Akcay M; Sari S
    Pediatr Dent; 2014; 36(4):316-21. PubMed ID: 25197997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars.
    Liu H; Zhou Q; Qin M
    Chin J Dent Res; 2011; 14(2):121-5. PubMed ID: 22319753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth.
    Moretti AB; Sakai VT; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Int Endod J; 2008 Jul; 41(7):547-55. PubMed ID: 18479381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars.
    Patidar S; Kalra N; Khatri A; Tyagi R
    J Indian Soc Pedod Prev Dent; 2017; 35(4):367-373. PubMed ID: 28914251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars.
    Shumayrikh NM; Adenubi JO
    Endod Dent Traumatol; 1999 Dec; 15(6):259-64. PubMed ID: 10825836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Tooth Vital Pulp Treatment Interventions: Systematic Review and Meta-Analyses.
    Coll JA; Dhar V; Chen CY; Crystal YO; Guelmann M; Marghalani AA; AlShamali S; Xu Z; Glickman G; Wedeward R
    Pediatr Dent; 2023 Nov; 45(6):474-546. PubMed ID: 38129755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.